[ WuXi NextCODE raises $75M in Series B funding ]

WuXi NextCODE has raised $75 million in Series B funding.

Founded in 2013, WuXi NextCODE is a fully integrated contract genomics organization building the global standard platform for genomic data.

The company rapidly expanding business is serving the world’s leading precision medicine initiatives as well as genome-driven diagnostics and wellness enterprises worldwide.

Funding  Series B
Founded  2013
Country  USA
City  Cambridge, Massachusetts
Founder / CEO  Hannes Thor Smárason
Deal Size  $75M
Investors  3W Partners
 Temasek Holdings
 YF Capital
 Amgen Ventures
Previous Investors  Polaris Partners
 ARCH Venture Partners

[adyen action=”checkout_button”]